Health Promotion and Human Behavior Kyoto University Graduate School of Medicine / School of Public Health
sww@ w ЉNwnU NiEsw HOME
Home > Publications > Publications
Publications

Publications in the last 5 years

2017

  1. Fujii T, Ganeko R, Kataoka Y, Furukawa TA, Featherstone R, Doi K, Vincent J-L, Pasero D, Robert R, Ronco C & Bagshaw SM (in press) Polymyxin B-immobilized hemoperfusion and mortality in critically ill patients with sepsis/septic shock: A systematic review and meta-analysis. Intensive Care Medicine.
  2. Furukawa TA, Horikoshi M, Fujita H, Tsujino N, Jinnin R, Kako Y, Ogawa S, Sato H, Kitagawa N, Shinagawa Y, Ikeda Y, Imai H, Tajika A, Ogawa Y, Akechi T, Yamada M, Shimodera S, Watanabe N, Inagaki M & Hasegawa A (in press) How do patients with major depression use and benefit from smartphone CBT? Content analyses of completed cognitive and behavioral skills exercises with Kokoro-app. JMIR Mental Health.
  3. Brignardello-Petersen R, Bonner A, Alexander PE, Siemieniuk RA, Furukawa TA, Rochwerg B, Hazlewood GS, Alhazzani W, Mustafa RA, Murad MH, Puhan MA, Schunemann HJ, Guyatt GH & Group GW (in press) Advances in the GRADE approach to rate the certainty in estimates from a network meta-analysis. Journal of Clinical Epidemiology.
  4. Noma H, Nagashima K, Maruo K, Gosho M & Furukawa TA (in press) Barlett-type corrections and bootstrap adjustments of likelihood-based inference methods for network meta-analysis. Statistics in Medicine.
  5. Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Yamada H & Furukawa TA (in press) Exponential distribution of total depressive symptom scores in relation to exponential latent trait and item threshold distributions: a simulation study. BMC Research Notes.
  6. Zhou X, Cipriani A, Furukawa TA, Cuijpers P, Zhang Y, Hetrick SE, Pu J, Yuan S, Del Giovane C & Xie P (in press) Comparative efficacy and tolerability of new-generation antidepressants for major depressive disorder in children and adolescents: protocol of an individual patient data meta-analysis. BMJ Open.
  7. Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Yamada H, Ono Y & Furukawa TA (in press) Item response patterns on the Patient Health Questionnaire-8 (PHQ-8) in a nationally representative sample of US adults. Frontiers in Psychiatry.
  8. Qin Z, Xie S, Mao Z, Liu Y, Wu J, Furukawa T, Kwong J, Tian J & Liu Z (in press) Comparative efficacy and acceptability of antiepileptic drugs for classical trigeminal neuralgia: A Bayesian network meta-analysis protocol. BMJ Open.
  9. Kimachi M, Furukawa TA, Kimachi K, Goto Y, Fukuma S & Fukuhara S (in press) Direct oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease. Cochrane Database of Systematic Reviews.
  10. Mantani A, Kato T, Furukawa TA, Horikoshi M, Imai H, Hiroe T, Chino B, Funayama T, Yonemoto N, Zhou Q & Kawanishi N (in press) Smartphone cognitive-behavior therapy as adjunct to pharmacotherapy for refractory depression: a randomized controlled trial. Journal of Medical Internet Research.
  11. Shinohara K, Aoki T, So R, Tsujimoto Y, Suganuma AM, Kise M & Furukawa TA (in press) The influence of overstated abstract conclusions on clinicians: A web-based randomized controlled trial. BMJ Open.
  12. Tsujimoto Y, Tsutsumi Y, Kataoka Y, Tsujimoto H, Yamamoto Y, Papola D, Guyatt GH, Fukuhara S & Furukawa TA (in press) Association between statistical significance and time to publication among systematic reviews: a study protocol for a meta-epidemiological investigation. BMJ Open.
  13. Ogawa Y, Furukawa TA, Takeshima N, Hayasaka Y, Atkinson LZ, Tanaka S, Cipriani A & Salanti G (in press) Efficacy of antidepressants over placebo is similar in two-armed versus three- or more-armed randomized placebo-controlled trials. International Clinical Psychopharmacology.
  14. Ogawa S, Imai R, Suzuki M, Furukawa TA & Akechi T (in press) The mechanisms underlying changes in broad dimensions of psychopathology during cognitive behavioural therapy for social anxiety disorder. Journal of Clinical Medicine Research.
  15. Yamada A, Suzuki M, Kyo M, Katsuki F, Shiraishi N, Watanabe N, Akechi T (2017) Group psychoeducational programs improve mood profiles in mothers of non-attendance school children. Neuropsychiatry (London), 7(5), 637-643.
  16. Shinohara K, Suganuma AM, Imai H, Takeshima N, Hayasaka Y & Furukawa TA (in press) Overstatements in abstract conclusions claiming effectiveness of interventions in psychiatry: A meta-epidemiological investigation. PLoS ONE.
  17. Ogawa S, Kondo M, Ino K, Ii T, Imai R, Furukawa TA & Akechi T (in press) Fear of fear and broad dimensions of psychopathology over the course of cognitive behavioural therapy for panic disorder with agoraphobia in Japan. East Asian Archives of Psychiatry.
  18. Iwakami N, Nagai T, Furukawa TA & Anzai T (in press) Response to letter regarding article by Formiga et al., " Utility of the Controlling Nutritional Status (CONUT) score in patients admitted due to acute heart failure" [Letter]. International Journal of Cardiology.
  19. Song L, Yoshida S, Tanaka-Mizuno S, Ogawa Y, Furukawa TA & Kawakami K (in press) Association between eicosapentaenoic acid (EPA) medication intake and new onset of depression among patients with hyperlipidemia: a 3-year follow-up study. Journal of Nutrition & Intermediary Metabolism.
  20. Omae K, Tsujimoto Y, Honda M, Kondo T, Tanabe K, Fukuhara S & Furukawa TA (in press) Comparative efficacy and safety of bone-modifying agents for the treatment of bone metastases in patients with advanced renal cell carcinoma: A systematic review and meta-analysis Oncotarget.
  21. Tomitaka S, Furukawa TA, Kawasaki Y, Ide K, Akutagawa M & Ono Y (in press) Characteristic distribution of the total and individual item scores on the Kessler Screening Scale for Psychological Distress (K6) in US adults. BMC Psychiatry.
  22. Katsura M, Kuriyama A, Tada M, Yamamoto K & Furukawa TA (in press) Redundant systematic reviews on the same topic in surgery: a study protocol for a meta-epidemiological investigation. BMJ Open.
  23. Samara MT, Goldberg Y, Levine SZ, Furukawa TA, Geddes JR, Cipriani A, David JM & Leucht S (in press) Initial severity of bipolar I disorder associated with the efficacy of olanzapine: Individual patient data meta-analysis of five placebo-controlled studies. Lancet Psychiatry.
  24. Imai H & Furukawa TA (in press) No significant difference in long-term remission between psychological therapies and antidepressants in panic disorder. Evidence-Based Mental Health.
  25. Guaiana G, Barbui C, Caldwell DM, Davies SJ, Furukawa TA, Imai H, Koesters M, Tajika A, Bighelli I, Pompoli A & Cipriani A (2017) Antidepressants, benzodiazepines and azapirones for panic disorder in adults: a network meta-analysis [Protocol]. Cochrane Database of Systematic Reviews, CD012729.
  26. Obbarius A, van Maasakkers L, Baer L, Clark DM, Crocker AG, De Beurs D, Emmelkamp PM, Furukawa TA, Hedman E, Kangas M, Langford L, Lesage A, Mwesigire DM, Nolte S, Patel V, Pilkonis PA, Pincus HA, Reis RA, Rojas G, Sherbourne C, Smithson D, Stowell C, Woolaway-Bickel K & Rose M (in press) Standardization of health outcome assessment for depression and anxiety: recommendations from the ICHOM Depression and Anxiety Working Group. Quality of Life Research.
  27. Jike M, Itani O, Watanabe N, Buysse DJ, & Kaneita Y (in press) Long sleep duration and health outcomes: A systematic review, meta-analysis and meta-regression. Sleep Medicine Reviews.
  28. Tsutsumi Y, Tsutsumi I, Tsujimoto Y, Takahashi s, Tsuchiya A, Miyakoshi C, Fukuma S & Furukawa TA (2017) Hyperbaric oxygen therapy for persistent post-concussion syndrome following mild traumatic brain injury [Protocol]. Cochrane Database of Systematic Reviews, CD012727.
  29. Zhou X, Cipriani A, Zhang Y, Cuijpers P, Hetrick SE, Weisz JR, Pu J, Giovane CD, Furukawa TA, Barth J, Coghill D, Leucht S, Yang L, Ravindran AV & Xie P (in press) Comparative efficacy and acceptability of antidepressants, psychological interventions, and their combination for depressive disorder in children and adolescents: protocol for a network meta-analysis. BMJ Open.
  30. Hashimoto K, Ogawa Y, Takeshima N & Furukawa TA (2017) Psychological and educational interventions for atopic dermatitis in adults: A systematic review and meta-analysis. Behaviour Change, 34, 48-65.
  31. Ito M, Horikoshi M, Resick PA, Katayanagi A, Miyamae M, Takagishi Y, Takebayashi Y, Kanie A, Hirabayashi N & Furukawa TA (in press) Study protocol for a randomized controlled trial of cognitive processing therapy for posttraumatic stress disorder among Japanese patients: the Safety, Power, Intimacy, Esteem, Trust (SPINET) study. BMJ Open.
  32. Imai H, Furukawa TA, Hayashi S, Goto A, Izumi K, Hayashino Y, Noda M for the J-DOIT2 Study Group (in press) Risk perception, self-efficacy, trust for physician, depression, and behavior modification in diabetic patients. Journal of Health Psycology.
  33. Okuyama T, Akechi T, Mackenzie L & Furukawa TA (2017) Psychotherapy for depression among advanced, incurable cancer patients: a systematic review and meta-analysis. Cancer Treatment Reviews, 56, 16-27.
  34. Morokuma Y, Endo K, Nishida A, Yamasaki S, Ando S, Morimoto Y, Nakanishi M, Okazaki Y, Furukawa TA, Morinobu S & Shimodera S (in press) Sex differences in auditory verbal hallucinations in early, middle, and late adolescence: Results from a survey of 17,451 Japanese students aged 12–18 years. BMJ Open.
  35. Imai H, Takeshima N, Oda H, Chen P, Sawada E & Furukawa TA (in press) Choto-san versus placebo for patients with dementia: Systematic review and meta-analysis. Psychogeriatrics.
  36. Furukawa TA (2017) Evidence-Based Case Conference (10) Prognosis of delirium. Evidence-Based Mental Health, 20, 53-54.
  37. Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Yamada H, Ono Y & Furukawa TA (2017) Pattern analysis of total item score and item response of the Kessler Screening Scale for Psychological Distress (K6) in a nationally representative sample of US adults. PeerJ, 5, e2987.
  38. Cuijpers P, Huibers MJ & Furukawa TA (in press) The need for research on treatments of chronic depression [Invited commentary]. JAMA Psychiatry.
  39. Kochi K, Sato I, Nishiyama C, Tanaka-Mizuno S, Doi Y, Arai M, Fujii Y, Matsunaga T, Ogawa Y, Furukawat TA & Kawakami K (in press) "Trends in antipsychotic prescriptions for Japanese outpatients during 2006-2012: a descriptive epidemiological study. Pharmacoepidemiology and Drug Safety.
  40. Cipriani A, Furukawa TA, Atkinson LZ, Leucht S & Salanti G (2017) DSM-III-R change in definition might have affected placebo response to antidepressants - Authors' reply. Lancet Psychiatry, 4, 22-23.
  41. Iwakami N, Nagai T, Furukawa TA, Sugano Y, Honda S, Okada A, Asaumi Y, Aiba T, Noguchi T, Kusano K, Ogawa H, Yasuda S, Anzai T & on behalf of the NaDEF investigators (in press) Prognostic value of malnutrition assessed by Controlling Nutritional Status score for long-term mortality in patients with acute heart failure. International Journal of Cardiology.
  42. Ostuzzi G, Bighelli I, So R, Furukawa TA & Barbui C (in press) Does formulataion matter? A systematic review and meta-analysis of oral versus long-acting antipsychotic studies. Schizophrenia Research.
  43. Kusaka K, Shinohara K, Tada M, Watanabe N & Furukawa TA (in press) Letter in response to "Randomized Controlled Trial of Family Therapy in Advanced Cancer Continued Into Bereavement": Concerns about Selective Outcome Reporting. Journal of Clinical Oncology.
  44. Noma H, Tanaka S, Matsui S, Cipriani A & Furukawa TA (in press) Quantifying indirect evidence in network meta-analysis. Statistics in Medicine.
  45. Ino K, Ogawa S, Kondo M, Imai R, Ii T, Furukawa TA & Akechi T (in press) Anxiety sensitivity as a predictor of broad dimensions of psychopathology after cognitive behavioral therapy for panic disorder. Neuropsychiatric Disease and Treatment.
  46. Furukawa TA, Weitz ES, Tanaka S, Hollon SD, Hofmann SG, Andersson G, Twisk J, DeRubeis RJ, Dimidjian S, Hegerl U, Mergl R, Jarrett RB, Vittengl JR, Watanabe N & Cuijpers P (in press) Initial severity of depression and efficacy of cognitive-behaviour therapy: An individual-participant data meta-analysis of pill-placebo-controlled trials. British Journal of Psychiatry.
  47. Ando S, Koike S, Nishida A, Yamasaki S, Shimodera S, Fujito R, Sawada K, Furukawa TA, Sasaki T, Inoue S, Okazaki Y & Asukai N (in press) Lithium levels in tap water and the mental health of adolescents: an individual level cross-sectional survey. Journal of Clinical Psychiatry.
  48. Ogawa S, Kondo M, Okazaki J, Imai R, Ino K, Furukawa TA & Akechi T (in press) The relationships between symptoms and quality of life over the course of cognitive-behavioral therapy for panic disorder in Japan. Asia-Pacific Psychiatry.
  49. Jinnin R, Okamoto Y, Takagaki K, Nishiyama Y, Yamamura T, Okamoto Y, Miyake Y, Takebayashi Y, Tanaka K, Sugiura Y, Shimoda H, Kawakami N, Furukawa TA & Yamawaki S (in press) Detailed course of depressive symptoms and risk for developing depression in late adolescents with subthreshold depression: cohort study. Neuropsychiatric Disease and Treatment.
  50. Itani O, Jike M, Watanabe N, Kaneita Y (2017) Short sleep duration and health outcomes: a systematic review, meta-analysis, and meta-regression. Sleep Medicine, 32, 246-256.
PAGE TOP

2016

  1. Barber S, Corsi M, Furukawa TA & Cipriani A (2016) Quality and impact of secondary information in promoting evidence-based clinical practice: a cross-sectional study about EBMH. Evidence-Based Mental Health, 19, 82-85.
  2. Bighelli I, Trespidi C, Castellazzi M, Cipriani A, Furukawa TA, Girlanda F, Gualana G, Koesters M & Barbui C (2016) Antidepressants and benzodiazepines for panic disorder in adults. Cochrane Database of Systematic Reviews, 9, CD011567.
  3. De Crescenzo F, Foti F, Ciabattini M, Giovane DC, Watanabe N, Schepisi MS, Quested DJ, Cipriani A, Barbui C, Amato L (2016) Comparative efficacy and acceptability of pharmacological treatments for insomnia in adults: a systematic review and network meta-analysis [Protocol]. Cochrane Database Systematic Reviews, 9, CD012364.
  4. Fujii T, Ganeko R, Kataoka Y, Featherstone R, Bagshaw SM & Furukawa TA (2016) Polymixin B-immobilized hemoperfusion and mortality in critically ill patients with sepsis/septic shock: Protocol for a systematic review and meta-analysis. BMJ Open, 6, e012908.
  5. Furukawa TA, Cipriani A, Atkinson LZ, Leucht S, Ogawa Y, Takeshima N, Hayasaka Y, Chaimani A & Salanti G (2016) Placebo response rates in antidepressant trials: a systematic review of published and unpublished double-blind randomised controlled studies. Lancet Psychiatry, 3, 1059-1066.
  6. Furukawa TA (2016) Evidence-Based Case Conference (9) Which psychotherapy for PTSD? Evidence-Based Mental Health, 19, 118-119.
  7. Honda M, Hiki N, Kinoshita T, Yabusaki H, Abe T, Nunobe S, Terada M, Matsuki A, Sunagawa H, Aizawa M, Healy MA, Iwasaki M & Furukawa TA (2016) Long-term Outcomes of Laparoscopic Versus Open Surgery for Clinical Stage I Gastric Cancer: The LOC-1 Study. Annals of Surgery, 264, 214-222.
  8. Furukawa TA, Salanti G, Atkinson L, Leucht S, Ruhe E, Turner EH, Chaimani A, Ogawa Y, Takeshima N, Hayasaka Y, Imai H, Shinohara K, Suganuma A, Watanabe N, Stockton S, Geddes J & Cipriani A (2016) Comparative efficacy and acceptability of first- and second-generation antidepressants in the acute treatment of major depression: Protocol for a network meta-analysis. BMJ Open, 6, e010919.
  9. Furukawa TA (2016) A guideline for whom? Epidemiology and Psychiatric Sciences, 25, 439-440.
  10. Furukawa TA, Schramm E, Weitz ES, Salanti G, Efthimiou O, Michalak J, Watanabe N, Cipriani A, Keller MB, Kocsis JH, Klein DN & Cuijpers P (2016) Cognitive-Behavioral Analysis System of Psychotherapy (CBASP), drug or their combination: Differential therapeutics for persistent depressive disorder: A study protocol of an individual participant data network meta-analysis. BMJ Open, 6, e011769.
  11. Furukawa TA (2016) Evidence-Based Case Conference (8) Diagnosing autism spectrum disorder (ASD) among adults. Evidence-Based Mental Health, 19, 46-48.
  12. Furukawa TA, Miura T, Chaimani A, Leucht S, Cipriani A, Noma H, Mitsuyasu H, Kanba S & Salanti G (2016) Using the contribution matrix to evaluate complex study limitations in a network meta-analysis: a case study of bipolar maintenance pharmacotherapy review. BMC Research Notes, 9, 218.
  13. Goto S, Hida K, Furukawa TA & Sakai Y (2016) Subcuticular sutures for skin closure in non-obstetric surgery [Protool]. Cochrane Database of Systematic Reviews.
  14. Hoshino N, Hasegawa S, Takada T, Hida K, Furukawa TA & Sakai Y (2016) Daikenchuto for reducing postoperative ileus in patients undergoing elective abdominal surgery [Protocol]. Cochrane Database of Systematic Reviews.
  15. Imai H, Tajika A, Chen P, Pompoli A & Furukawa TA (2016) Psychological therapies versus pharmacological interventions for panic disorder with or without agoraphobia in adults. Cochrane Database of Systematic Reviews, 10, CD011170.
  16. Kanata S, Koike S, Ando S, Nishida A, Usami S, Yamasaki S, Morimoto Y, Toriyama R, Fujikawa S, Sugimoto N, Sasaki T, Furukawa TA, Hiraiwa-Hasegawa M & Kasai K (2016) Enuresis and Hyperactivity-Inattention in Early Adolescence: Findings from a Population-Based Survey in Tokyo (Tokyo Early Adolescence Survey). PLoS ONE, 11, e0158786.
  17. Leucht S, Chaimani A, Cipriani AS, Davis JM, Furukawa TA & Salanti G (2016) Network meta-analyses should be the highest level of evidence in treatment guidelines. European Archives of Psychiatry and Clinical Neuroscience, 266, 477-480.
  18. Levine SZ, Kodesh A, Goldberg Y, Reichenberg A, Furukawa TA, Klevzon A & Leucht S (2016) Initial severity and efficacy of risperidone in autism: Results from the RUPP trial. European Psychiatry, 32, 16
  19. Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O & Salanti G (2016) Psychological therapies for panic disorder with or without agoraphobia in adults: a network meta-analysis. Cochrane Database of Systematic Reviews, 4, CD011004.
  20. Ogawa S, Kondo M, Ino K, Imai R, Ii T, Furukawa TA & Akechi T (2016) Anxiety sensitivity and comorbid psychiaric symptoms over the course of cognitive behavioural therapy for panic disorder. British Journal of Medicine and Medical Research, 13, 1-7.
  21. Ogawa S, Imai R, Kondo M, Furukawa TA & Akechi T (2016) Predictors of comorbid psychological symptoms among patients with social anxiety disorder after cognitive-behavioral therapy. Open Journal of Psychiatry, 6, 102-106.
  22. Onishi A & Furukawa TA (2016) State-of-the-Art Reporting. In Umbrella Reviews: Evidence Synthesis with Overviews of Reviews and Meta-Epidemiologic Studies. (ed Biondi-Zoccai G), pp. 189-202. Heidelberg, New York, Dordrecht, London: Springer International Publishing.
  23. Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, Okamoto Y, Miyake Y, Ogata A, Kunisato Y, Shimoda H, Kawakami N, Furukawa TA & Yamawaki S (2016) Behavioral activation for late adolescents with subthreshold depression: a randomized controlled trial. European Child and Adolescent Psychiatry, 25, 1171-1182.
  24. Takagaki K, Okamoto Y, Jinnin R, Mori A, Nishiyama Y, Yamamura T, Yokoyama S, Shiota S, Okamoto Y, MIyake Y, Ogata A, Shimoda H, Kawakami N, Furukawa TA & Yamawaki S (2016) Mechanisms of behavioral activation for late adolescent: Positive reinforcement mediate the relationship between activation and depressive symptoms from pre-treatment to post-treatment. Journal of Affective Disorders, 204, 70-73.
  25. Takekita Y, Suwa T, Sunada N, Kawashima H, Fabbri C, Kato M, Tajika A, Kinoshita T, Furukawa TA & Serretti A (2016) Remifentanil in electroconvulsive therapy: a systematic review and meta-analysis of randomized controlled trials. European Archives of Psychiatry and Clinical Neuroscience, 266, 703-717.
  26. Takeshima N, Ogawa Y, Hayasaka Y & Furukawa TA (2016) Continuation and discontinuation of benzodiazepine prescriptions: A cohort study based on a large claims database in Japan. Psychiatry Research, 237, 201-207.
  27. Tomitaka S, Kawasaki Y, Ide K, Yamada H, Miyake H & Furukawa TA (2016) Distribution of Total Depressive Symptoms Scores and Each Depressive Symptom Item in a Sample of Japanese Employees. PLoS ONE, 11, e0147577.
  28. Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Yamada H, Furukawa TA & Ono Y (2016) Boundary curves of individual items in the distribution of total depressive symptom scores approximate an exponential pattern in a general population. PeerJ, 4, e2566.
  29. Tomitaka S, Kawasaki Y, Ide K, Akutagawa M, Yamada H, Furukawa TA & Ono Y (2016) Relationship between Item Responses of Negative Affect Items and the Distribution of the Sum of the Item Scores in the General Population. PLoS ONE, 11, e0165928.
  30. Tomitaka S, Kawasaki Y, Ide K, Yamada H, Furukawa TA & Ono Y (2016) Age-related changes in the distributions of depressive symptom items in the general population: Cross-sectional study using the exponential distribution model. PeerJ, 4, e1547.
  31. Suganuma AM, Shinohara K, Imai H, Takeshima N, Hayasaka Y & Furukawa TA (2016) Overstatements in abstract conclusions claiming effectiveness of interventions in psychiatry: a study protocol for a meta-epidemiological investigation. BMJ Open, 6, e009832.
  32. Yamada A, Miyachi N, Miura T, Suzuki M, Watanabe N, Akechi T (2016) Long-term poor rapport, lack of spontaneity and passive social withdrawal related to acute post-infectious encephalitis: a case report. SpringerPlus, 5, 345.
  33. Yamasaki S, Ando S, Koike S, Usami S, Endo K, French P, Sasaki T, Furukawa TA, Hasegawa-Hiraiwa M, Kasai K & Nishida A (2016) Dissociation mediates the relationship between peer victimizatiion and hallucinatory experiences among early adolescents. Psychiatry Research: Cognition, 4, 18-23.
  34. Zhao YJ, Lin L, Teng M, Khoo AL, Soh LB, Furukawa TA, Baldessarini RJ, Lim BP & Sim K (2016) Long-term antipsychotic treatment in schizophrenia: Systematic review and network meta-analysis of randomised controlled trials. BJPsych Open, 2, 59-66.
PAGE TOP

2015

  1. Akechi T & Furukawa TA (2015) Depressed with cancer can respond to antidepressants, but further research is needed to confirm and expand on these findings. Evidence-Based Mental Health, 18, 28.
  2. Caddy C, Amit BH, McCloud TL, Rendell JM, Furukawa TA, McShane R, Hawton K & Cipriani A (2015) Ketamine and other glutamate receptor modulators for depression in adults. Cochrane Database of Systematic Reviews, CD011612.
  3. Chaudhry H, Foote CJ, Guyatt G, Thabane L, Furukawa TA, Petrisor B & Bhandari M (2015) Network Meta-analysis: Users' Guide for Surgeons: Part II - Certainty. Clinical Orthopaedics and Related Research, 473, 2172-2178.
  4. Foote CJ, Chaudhry H, Bhandari M, Thabane L, Furukawa TA, Petrisor B & Guyatt G (2015) Network Meta-analysis: Users' Guide for Surgeons: Part I - Credibility. Clinical Orthopaedics and Related Research, 473, 2166-2171.
  5. Furukawa TA, Levine SZ, Tanaka S, Goldberg Y, Samara M, Davis JM, Cipriani A & Leucht S (2015) Initial severity of schizophrenia and efficacy of antipsychotics: Participant-level meta-analysis of 6 placebo-controlled studies. JAMA Psychiatry, 72, 14-21.
  6. Furukawa TA (2015) Evidence-based case conference (5) Helping people with schizophrenia to quit smoking. Evidence-Based Mental Health, 18, 14-15.
  7. Furukawa TA (2015) Evidence-based case conference (6) Which drug is the best bet when your bipolar patient gets depressed? Evidence-Based Mental Health, 18, 80-81.
  8. Furukawa TA (2015) Evidence-based case conference (7) What course are we to expect for a child with her first manic episode? Evidence-Based Mental Health, 18, 111-112.
  9. Furukawa TA (2015) The relationship between depression and violent crime [Invited commentary]. Lancet Psychiatry, 2, 193-194.
  10. Hayasaka Y, Purgato M, Magni LR, Ogawa Y, Takeshima N, Cipriani A, Barbui C, Leucht S & Furukawa TA (2015) Dose equivalents of antidepressants: Evidence-based recommendations from randomized controlled trials. Journal of Affective Disorders, 180, 179-184.
  11. Hayasaka Y, Furukawa TA, Sozu T, Imai H, Kawakami N & Horikoshi M (2015) Enthusiasm for homework and improvement in subthreshold depression during behavior therapy: Secondary analysis of data from a randomized controlled trial. BMC Psychiatry, 15, 302.
  12. Imai H, Furukawa TA, Okumiya K, Wada T, Fukutomi E, Sakamoto R, Fujisawa M, Ishimoto Y, Kimura Y, Chen WL, Tanaka M & Matsubayashi K (2015) Postcard intervention for depression in community-dwelling older adults: A randomised controlled trial. Psychiatry Research, 229, 545-550.
  13. Imamura K, Kawakami N, Furukawa TA, Matsuyama Y, Shimazu A, Umanodan R, Kawakami S & Kasai K (2015) Does Internet-based cognitive behavioral therapy (iCBT) prevent major depressive episode for workers? A 12-month follow-up of a randomized controlled trial. Psychological Medicine, 45, 1907-1917.
  14. Imamura K, Kawakami N, Furukawa TA, Matsuyama Y, Shimazu A, Umanodan R, Kawakami S & Kasai K (2015) Effects of an internet-based cognitive behavioral therapy intervention on improving work engagement and other work-related outcomes: an analysis of secondary outcomes of a randomized controlled trial. Journal of Occupational and Environmental Medicine, 57, 578-584.
  15. Imamura K, Kawakami N, Furukawa TA, Matsuyama Y, Shimazu A, Umanodan R, Kawakami S & Kasai K (2015) Effects of an internet-based cognitive behavioral therapy (iCBT) intervention on preventing major depressive episode among workers: A protocol for a randomized controlled trial. BMJ Open, 5, e007590.
  16. Johnston BC, Ebrahim S, Carrasco-Labra A, Furukawa TA, Patrick D, Crawford MW, Hemmelgarn BR, Schunemann HJ, Guyatt GH & Nesrallah G (2015) Minimally important difference estimates and methods: A protocol. BMJ Open, 5, e007953.
  17. Katsura M, Kuriyama A, Takeshima T, Fukuhara S & Furukawa TA (2015) Preoperative inspiratory muscle training for postoperative pulmonary complications in adult patients undergoing cardiac and major abdominal surgery. Cochrane Database of Systematic Reviews, CD010356.
  18. Kondo M, Kiyomizu K, Goto F, Kitahara T, Imai T, Hashimoto M, Shijogori H, Ikezono T, Nakayama J, Watanabe N, Akechi T (2015) Analysis of vestibular-balance symptoms according to sympotom duration: Dimensionality of the Vertigo Symptom Scale-short form. Health and Quality of Life Outcomes, 13, 4.
  19. Leucht S, Samara M, Heres S, Patel MX, Furukawa T, Cipriani A, Geddes J & Davis JM (2015) Dose equivalents for second-generation antipsychotic drugs: the classical mean dose method. Schizophrenia Bulletin, 41, 1397-1402.
  20. Onishi A, Iwasaku M, Sato A & Furukawa TA (2015) Interventions for the management of esophageal candidasis in immunocomopromised patients [Protocol]. Cochrane Database of Systematic Reviews, CD011938.
  21. Obbarius A, Clark D, Crocker AG, Emmelkamp P, Furukawa TA, Hedman E, Kangas M, Lesage A, Mwesigire DM, Nolte S, Patel V, Pilkonis P, Pincus HA, Reis RA, Rojas G, Sherbourne C, Stowell C & Rose M (2015) A proposal for standardization of health outcome measures for depression and anxiety. Quality of Life Research, 24, 110-111.
  22. Sakai K, Fujita K, Sozu T, Nakayama T & Furukawa TA (2015) Eradication of helicobacter pylori for iron metabolism [Protocol]. Cochrane Database of Systematic Reviews, CD011480.
  23. Sugihara G & Tajika A (2015) Can we predict switch from unipolar depression to bipolar disorder? [Letter]. British Journal of Psychiatry, 206, 79.
  24. Shinohara K, Tajika A, Imai H, Takeshima N, Hayasaka Y & Furukawa TA (2015) Protocol registration and selective outcome reporting in recent psychiatry trials: new antidepressants and cognitive behavioural therapies. Acta Psychiatrica Scandinavica, 132, 489-498.
  25. Tajika A, Ogawa Y, Takeshima N, Hayasaka Y & Furukawa TA (2015) Replication and contradiction of highly cited research papers in psychiatry: 10-year follow-up. British Journal of Psychiatry, 207, 357-362.
  26. Tomitaka S, Kawasaki Y & Furukawa TA (2015) Right tail of the distribution of depressive symptoms is stable and follows an exponential curve during middle adulthood. PLoS ONE, 10, e0114624.
  27. Tomitaka S, Kawasaki Y & Furukawa TA (2015) A distribution model of the responses to each depressive symptoms item in a general population. Cross-sectional study. BMJ Open, 5, e008599.
  28. Watanabe K, Yokoyama K & Furukawa TA (2015) Reliability and validity of the Japanese version of the coping inventory for adults for stressful situations in healthy people. Psychological Reports, 116, 447-469.
  29. Watanabe N, Furukawa TA, Shimodera S, Katsuki F, Fujita H, Sasaki M, Sado M & Perlis ML (2015) Cost-effectiveness of cognitive behavioral therapy for insomnia comorbid with depression: Analysis of a randomized controlled trial. Psychiatry and Clinical Neurosciences, 69, 335-343.
  30. Watanabe N, Furukawa TA, Horikoshi M, Katsuki F, Narisawa T, Kumachi M, Oe Y, Shinmei I, Noguchi H, Hamazaki K & Matsuoka Y (2015) A mindfulness-based stress management program and treatment with omega-3 fatty acids to maintain a healthy mental state in hospital nurses - Happy Nurse Project: study protocol for a randomized controlled trial. Trials, 16, 36.
  31. Watanabe N, Horikoshi M, Yamada M, Shimodera S, Akechi T, Miki K, Inagaki M, Yonemoto N, Imai H, Tajika A, Ogawa Y, Takeshima N, Hayasaka Y & Furukawa TA (2015) Adding smartphone-based cognitive-behaviour therapy to pharmacotherapy for major depression (FLATT project): study protocol for a randomized controlled trial. Trials, 16, 293.
  32. Yonemoto N, Tanaka S, Furukawa TA, Kato T, Mantani A, Ogawa Y, Tajika A, Takeshima N, Hayasaka Y, Shinohara A, Miki K, Inagaki M, Shimodera S, Akechi T, Yamada M, Watanabe N & Guyatt GH (2015) Strategic Use of New generation antidepressants for Depression: SUN(^_^)D protocol update and statistical analysis plan. Trials, 16, 459.
  33. Zhang Y, Zhang S, Thabane L, Furukawa TA, Johnston BC & Guyatt GH (2015) Although not consistently superior, the absolute approach to framing the minimally important difference has advantages over the relative approach. Journal of Clinical Epidemiology, 68, 888-894.
PAGE TOP

2014

  1. Banno K, Nakaaki S, Sato J, Torii K, Oka M, Negi A, Narumoto J, Miyata J, Hirono N, Furukawa TA, Mimura M & Akechi T (2014) Neural basis of three dimensions of agitated behaviors in patients with Alzheimer disease. Neuropsychiatric Disease and Treatment, 10, 339-348.
  2. Chen P, Furukawa TA, Shinohara K, Honyashiki M, Imai H, Ichikawa K, Caldwell DM, Hunot V & Churchill R (2014) Quantity and quality of psychotherapy trials for depression in the past five decades. Journal of Affective Disorders, 165, 190-195.
  3. Cipriani A & Furukawa TA (2014) Advancing evidence-based practice to improve patient care. Evidence-Based Mental Health, 17, 1-2.
  4. Furukawa TA (2014) How can we make the results of trials and their meta-analyses using continuous outcomes clinically interpretable? Acta Psychiatrica Scandinavica, 130, 321-323.
  5. Furukawa TA & Guyatt G (2014) An illustration of bias and random error. In Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice (3rd edn). (eds Guyatt G, Rennie D, Meade MO & Cook DJ), pp. 103-106. New York: The McGraw-Hill Companies, Inc.
  6. Furukawa TA, Scott I & Guyatt G (2014) Measuring patients' experience. In Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice (3rd edn). (eds Guyatt G, Drummond R, Meade MO & Cook DJ), pp. 219-234. New York: The McGraw-Hill Companies, Inc.
  7. Furukawa TA, Strauss S, Bucher HC, Agoritsas T & Guyatt G (2014) Diagnostic tests. In Users' Guides to the Medical Literature: A Manual for Evidence-Based Practice (3rd edn). (eds Guyatt G, Drummond R, Meade MO & Cook DJ), pp. 345-358. New York: The McGraw-Hill Companies, Inc.
  8. Furukawa TA (2014) Anxiety disorders in non-Western cultures. In The Whiley Handbook of Anxiety Disorders. (eds Emmelkamp P & Ehring T), pp. 612-621. Chichester, UK: John Wiley & Sons, Ltd.
  9. Furukawa TA (2014) Case study in psychiatry. In Network Meta-Analysis: Evidence Synthesis with Mixed Treatment Comparison. (ed Biondi-Zoccai G). Hauppauge, NY: Nova Science Publishers.
  10. Furukawa TA (2014) Evidence-Based Case Conference (1) Antidepressants during ECT. Evidence-Based Mental Health, 17, 25-26.
  11. Furukawa TA (2014) Evidence-Based Case Conference (2) Diagnostic test for dementias. Evidence-Based Mental Health, 17, 45-46.
  12. Furukawa TA (2014) Evidence-Based Case Conference (3) Prognosis of a brief psychotic episode. Evidence-Based Mental Health, 17, 81-82.
  13. Furukawa TA (2014) Evidence-Based Case Conference (4) Adverse effects of antidepressants during pregnancy. Evidence-Based Mental Health, 17, 103-104.
  14. Furukawa TA, Noma H, Caldwell DM, Honyashiki M, Shinohara K, Imai H, Chen P, Hunot V & Churchill R (2014) Waiting list may be a nocebo condition in psychotherapy trials: a contribution from network meta-analysis. Acta Psychiatrica Scandinavica, 130, 181-192.
  15. Furukawa TA, Watanabe N, Kinoshita Y, Kinoshita K, Sasaki T, Nishida A, Okazaki Y & Shimodera S (2014) Public speaking fears and their correlates among 17,615 Japanese adolescents. Asia-Pacific Psychiatry, 6, 99-104.
  16. Hashimoto N, Nakaaki S, Kawaguchi A, Sato J, Kasai H, Nakamae T, Narumoto J, Miyata J, Furukawa TA & Mimura M (2014) Brain structural abnormalities in behavior therapy-resistant obsessive-compulsive disorder revealed by voxel-based morphometry. Neuropsychiatric Disease and Treatment, 10, 1987-1996.
  17. Honda M, Kuriyama A & Furukawa TA (2014) Comments on "Omentum-preserving gastrectomy for advanced gastric cancer: a propensity-matched retrospective cohort study". Gastric Cancer, 17, 757-758.
  18. Honda M, Kuriyama A, Noma H, Nunobe S & Furukawa TA (2014) Reply to Letter: "The Meta-analyses With Transparency Are Needed". Annals of Surgery.
  19. Honda M, Yamamoto K & Furukawa TA (2014) Retrospective propensity score matching and the selection of surgical procedures: how precise can a propensity estimate be? Journal of Clinical Oncology, 32, 3200-3201.
  20. Honyashiki M, Furukawa TA, Noma H, Tanaka S, Chen P, Ichikawa K, Ono M, Churchill R, Hunot V & Caldwell DM (2014) Specificity of CBT for depression: a contribution from multiple treatments meta-analyses. Cognitive Therapy and Research, 38, 249-260.
  21. Imai H, Furukawa TA, Kasahara Y, Ishimoto Y, Kimura Y, Fukutomi E, Chen WL, Tanaka M, Sakamoto R, Wada T, Fujisawa M, Okumiya K & Matsubayashi K (2014) The ipsative imputation for a 15-item Geriatric Depression Scale in community-dwelling elderly people. Psychogeriatrics, 14, 182-187.
  22. Imai H, Tajika A, Chen L, Pompoli A & Furukawa TA (2014) Psychological therapies versus pharmacological interventions for panic disorder [Protocol]. Cochrane Database of Systematic Reviews, CD011170.
  23. Imai H, Tajika A, Chen P, Pompoli A, Guaiana G, Castellazzi M, Bighelli I, Girlanda F, Barbui C, Koesters M, Cipriani A & Furukawa TA (2014) Azapirone versus placebo for panic disorder in adults. Cochrane Database of Systematic Reviews, CD010828.
  24. Imamura K, Kawakami N, Furukawa TA, Matsuyama Y, Shimazu A, Umanodan R, Kawakami S & Kasai K (2014) Effects of an internet-based cognitive behavioral therapy (iCBT) program in Manga format on improving subthreshold depressive symptoms among healthy workers: A randomized controlled trial. PLoS ONE, 9, e97167.
  25. Katsura M, Kuriyama A, Takeshima T, Fukuhara S & Furukawa TA (2014) Preoperative inspiratory muscle training for postoperative pulmonary complications in adult patients undergoing cardiac and major abdominal surgery [Protocol]. Cochrane Database of Systematic Reviews, CD010356.
  26. Kimachi M, Furukawa TA, Kimachi K, Goto Y & Fukuhara S (2014) New oral anticoagulants versus warfarin for preventing stroke and systemic embolic events among atrial fibrillation patients with chronic kidney disease [Protocol]. Cochrane Database of Systematic Reviews, CD011373.
  27. Miura T, Furukawa TA, Cipriani A, Motomura K, Mitsuyasu H, Tanaka S, Leucht S, Shimano-Katsuki S, Salanti G, Noma H, Stockton S, Geddes JR & Kanba S (2014) Bipolar treatment efficacy - Author's replay. Lancet Psychiatry, 1, 418-419.
  28. Miura T, Noma H, Furukawa TA, Mitsuyasu H, Tanaka S, Stockton S, Salanti G, Motomura K, Shimano-Katsuki S, Leucht S, Cipriani A, Geddes JR & Kanba S (2014) Comparative efficacy and tolerability of pharmacological treatments in the maintenance treatment of bipolar disorder: A network meta-analysis. Lancet Psychiatry, 1, 351-359.
  29. Ogawa Y, Tajika A, Takeshima N, Hayasaka Y & Furukawa TA (2014) Mood stabilizers and antipsychotics for acute mania: a systematic review and meta-analysis of combination/augmentation therapy versus monotherapy. CNS Drugs, 28, 989-1003.
  30. Onishi A & Furukawa TA (2014) Publication bias is underreported in systematic reviews published in high-impact-factor journals: metaepidemiologic study. Journal of Clinical Epidemiology, 67, 1320-1326.
  31. Onishi A, Sato A, Iwasaku M & Furukawa TA (2014) Human parathyroid hormone for treating glucocorticoid-induced osteoporosis [Protocol]. Cochrane Database of Systematic Reviews, CD011299.
  32. Pompoli A, Furukawa TA, Imai H, Tajika A, Efthimiou O & Salanti G (2014) Psychological therapies for panic disorder with or without agoraphobia in adults [Protocol]. Cochrane Database of Systematic Reviews, CD011004.
  33. Purgato M, Papola D, Gastaldon C, Trespidi C, Magni LR, Rizzo C, Furukawa TA, Watanabe N, Cipriani A & Barbui C (2014) Paroxetine versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews, CD006531.
  34. Shimodera S, Watanabe N, Furukawa TA, Katsuki F, Fujita H, Sasaki M & Perlis ML (2014) Change in quality of life afer brief behavioural therapy for insomnia in concurrent depression: Analysis of the effects of a randomized controlled trial. Journal of Clinical Sleep Medicine, 10, 433-439.
  35. Shiraishi N, Nishida A, Shimodera S, Sasaki T, Oshima N, Watanabe N, Akechi T, Furukawa TA & Okazaki Y (2014) Relationship between Violent Behavior and Repeated Weight-Loss Dieting among Female Adolescents in Japan. PLoS ONE, 9, e107744.
  36. Shiraishi N, Watanabe N, Kinoshita Y, Kaneko A, Yoshida S, Furukawa TA & Akechi T (2014) Brief psychoeducation for schizophrenia primarily intended to change the cognition of auditory hallucinations: an exploratory study. Journal of Nervous and Mental Disease, 202, 35-39.
  37. Suzuki M, Yamada A, Watanabe N, Akechi T, Katsuki F, Nishiyama T, Imaeda M, Miyachi T, Otaki K, Mitsuda Y, Ota A & Furukawa TA (2014) A failure to confirm the effectiveness of a brief group psychoeducational program for mothers of children with high-functioning pervasive developmental disorders: A randomized controlled pilot trial. Neuropsychiatric Disease and Treatment, 10, 1141-1153.
  38. Takeshima N, Furukawa TA, Hayasaka Y, Ogawa Y & Tajika A (2014) Ramelteon for primary insomnia [Protocol]. Cochrane Database of Systematic Reviews, CD011049.
  39. Takeshima N, Sozu T, Tajika A, Ogawa Y, Hayasaka Y & Furukawa TA (2014) Which is more generalizable, powerful and interpretable in meta-analyses, mean difference or standardized mean difference? BMC Medical Research Methodology, 14, 30.
  40. Tomitaka S & Furukawa TA (2014) Mathematical model for the distribution of major depressive episode durations. BMC Research Notes, 7, 636.
  41. Yamamoto K, Honda M & Furukawa TA (2014) Video-assisted thoracoscopic surgery lobectomy or open lobectomy for non-small-cell lung cancer? Minimizing selection bias in observational studies. European Journal of Cardio-Thoracic Surgery, 46, 150.
PAGE TOP

2013

  1. Ando S, Yamasaki S, Shimodera S, Sasaki T, Oshima N, Furukawa TA, Asukai N, Kasai K, Mino Y, Inoue S, Okazaki Y & Nishida A (2013) A greater number of somatic pain sites is associated with poor mental health in adolescents: a cross-sectional study. BMC Psychiatry, 13, 30.
  2. Churchill R, Moore TH, Furukawa TA, Caldwell DM, Davies P, Jones H, Shinohara K, Imai H, Lewis G & Hunot V (2013) 'Third wave' cognitive and behavioural therapies versus treatment as usual for depression. Cochrane Database of Systematic Reviews, 10, CD008705.
  3. Funayama T, Furukawa TA, Nakano Y, Noda Y, Ogawa S, Watanabe N, Chen J & Noguchi Y (2013) In-situation safety behaviors among patients with panic disorder: descriptive and correlational study. Psychiatry and Clinical Neurosciences, 67, 332-339.
  4. Furukawa TA & Leucht S (2013) Can we inflate effect size and thus increase chances of producing "positive" results if we raise the baseline threshold in schizophrenia trials? Schizophrenia Research, 144, 105-108.
  5. Furukawa TA, Nakano Y, Funayama T, Ogawa S, Ietsugu T, Noda Y, Chen J, Watanabe N & Akechi T (2013) Cognitive-behavioral therapy modifies the naturalistic course of social anxiety disorder: Findings from an ABA design study in routine clinical practices. Psychiatry and Clinical Neurosciences, 67, 139-147.
  6. Furukawa TA, Onishi Y, Hinotsu S, Tajika A, Takeshima N, Shinohara K, Ogawa Y, Hayasaka Y & Kawakami K (2013) Prescription patterns following first-line new generation antidepressants for depression in Japan: a naturalistic cohort study based on a large claims database. Journal of Affective Disorders, 150, 916-922.
  7. Guyatt GH, Thorlund K, Oxman AD, Walter SD, Patrick D, Furukawa TA, Johnston BC, Karanicolas P, Akl EA, Vist G, Kunz R, Brozek J, Kupper LL, Martin SL, Meerpohl JJ, Alonso-Coello P, Christensen R & Schunemann HJ (2013) GRADE guidelines: 13. Preparing Summary of Findings tables and evidence profiles-continuous outcomes. Journal of Clinical Epidemiology, 66, 173-183.
  8. Honda M, Kuriyama A, Noma H, Nunobe S & Furukawa TA (2013) Hand-Sewn Versus Mechanical Esophagogastric Anastomosis After Esophagectomy: A Systematic Review and Meta-Analysis. Annals of Surgery, 257, 238-248.
  9. Hunot V, Moore TH, Caldwell DM, Furukawa TA, Davies P, Jones H, Honyashiki M, Chen P, Lews G & Churchill R (2013) 'Third wave' cognitive and behavioural therapies versus other psychological therapies for depression. Cochrane Database of Systematic Reviews, 10, CD008704.
  10. Imai H, Furukawa TA, Okumiya K, Wada T, Fukutomi E, Sakamoto R, Fujisawa M, Ishimoto Y, Kimura Y, Chen WL, Tanaka M & Matsubayashi K (2013) The postcard intervention against depression among community-dwelling older adults: study protocol for a randomized controlled trial. Trials, 14, 202.
  11. Imai H, Tajika A, Chen P, Pompoli A, Guaiana G, Castellazzi M, Bighelli I, Girlanda F, Barbui C, Koesters M, Cipriani A & Furukawa TA (2013) Azapirone versus placebo for panic disorder in adults [Protocol]. Cochrane Database of Systematic Reviews.
  12. Inagaki M, Ohtsuki T, Yonemoto N, Kawashima Y, Saitoh A, Oikawa Y, Kurosawa M, Muramatsu K, Furukawa TA & Yamada M (2013) Validity of the Patient Health Questionnaire (PHQ)-9 and PHQ-2 in general internal medicine primary care at a Japanese rural hospital: a cross-sectional study. General Hospital Psychiatry, 35, 592-597.
  13. Inagaki M, Ohtsuki T, Yonemoto N, Oikawa Y, Kurosawa M, Muramatsu K, Furukawa TA & Yamada M (2013) Prevalence of depression among outpatients visiting a general internal medicine polyclinic in rural Japan. General Hospital Psychiatry, 35, 286-290.
  14. Kawaguchi A, Watanabe N, Nakano Y, Ogawa S, Suzuki M, Kondo M, Furukawa TA & Akechi T (2013) Group cognitive behavioral therapy for patients with generalized social anxiety disorder in Japan: outcomes at 1-year follow up and outcome predictors. Neuropsychiatric Disease and Treatment, 9, 1-9.
  15. Kawamura A, Shimodera S, Furukawa TA, Kumagai N, Nishida A, Mizuno M & Inoue S (2013) Effect of depression-related somatic pain on treatment satisfaction and daily living functions. International Journal of Psychiatry in Medicine, 46, 27-38.
  16. Kido Y, Kawakami N & WHO World Mental Health Japan Survey Group (2013) Sociodemographic determinants of attitudinal barriers in the use of mental health services in Japan: Findings from the World Mental Health Japan Survey 2002–2006. Psychiatry and Clinical Neurosciences, 67, 101-109.
  17. Kinoshita Y, Furukawa TA, Kinoshita K, Honyashiki M, Omori IM, Marshall M, Bond GR, Huxley P, Amano N & Kingdon D (2013) Supported employment for adults with severe mental illness. Cochrane Database of Systematic Reviews, 9, CD008297.
  18. Magni LR, Purgato M, Gastaldon C, Papola D, Furukawa TA, Cipriani A & Barbui C (2013) Fluoxetine versus other types of pharmacotherapy for depression. Cochrane Database of Systematic Reviews, 7, CD004185.
  19. Morokuma I, Shimodera S, Fujita H, Hashizume H, Kamimura N, Kawamura A, Nishida A, Furukawa TA & Inoue S (2013) Psychoeducation for major depressive disorders: a randomised controlled trial. Psychiatry Research, 210, 134-139.
  20. Nakaaki S, Sato J, Torii K, Oka M, Negi A, Nakamae T, Narumoto J, Miyata J, Furukawa TA & Mimura M (2013) Diffusion white matter integrity before the onset of delusions in patients with Alzheimer's disease: Diffusion tensor imaging. Neuropsychiatric Disease and Treatment, 9, 25-29.
  21. Nakaaki S, Sato J, Torii K, Oka M, Negi A, Nakamae T, Narumoto J, Miyata J, Furukawa TA & Mimura M (2013) Neuroanatomical abnormalities before the onset of delusions in patients with Alzheimer's disease: A voxel-based morphometry study. Neuropsychiatric Disease and Treatment, 9, 1-8.
  22. Nakano Y, Akechi T, Furukawa TA & Sugiura-Ogasawara M (2013) Cognitive behavior therapy for psychological distress in patients with recurrent miscarriage. Psychology Research and Behavior Management, 6, 37-43.
  23. Onishi Y, Hinotsu S, Furukawa TA & Kawakami K (2013) Psychotropic prescription patterns among patients diagnosed with depressive disorder based on claims database in Japan. Clinical Drug Investigation, 33, 597-605.
  24. Samara MT, Spineli LM, Furukawa TA, Engel RR, Davis JM, Salanti G & Leucht S (2013) Imputation of response rates from means and standard deviations in schizophrenia. Schizophrenia Research, 151, 209-214.
  25. Sato J, Nakaaki S, Torii K, Oka M, Negi A, Tatsumi H, Narumoto J, Furukawa TA & Mimura M (2013) Behavior management approach for agitated behavior in Japanese patients with dementia: A pilot study. Neuropsychiatric Disease and Treatment, 9, 9-14.
  26. Shinohara K, Honyashiki M, Imai H, Hunot V, Caldwell D, Davies P, Moore TH, Furukawa TA & Churchil R (2013) Behavioural therapies versus other psychological therapies for depression. Cochrane Database of Systematic Reviews, 10, CD008696.
  27. So M, Yamaguchi S, Hashimoto S, Sado M, Furukawa TA & McCrone P (2013) Is computerised CBT really helpful for adult depression?-A meta-analytic re-evaluation of CCBT for adult depression in terms of clinical implementation and methodological validity. BMC Psychiatry, 13, 113.
  28. Sugiura-Ogasawara M, Nakano Y, Ozaki Y & Furukawa T (2013) Possible involvement of depression after systematic examination and explanation of live birth rates among women with recurrent miscarriage. Journal of Obstetrics and Gynaecology, 33, 171-174.
  29. Watanabe N, Furukawa TA, Shimodera S, Katsuki F, Fujita H, Sasaki M, Suga Y, Kakeda K & Perlis ML (2013) Can assessors in a trial of psychotherapy be successfully blinded? Analysis of a randomized controlled trial on psychotherapy for refractory insomnia in residual depression. Psychotherapy and Psychosomatics, 82, 401-403.
PAGE TOP

2012

  1. Cipriani A, Koesters M, Furukawa TA, Nose M, Purgato M, Omori IM, Trespidi C & Barbui C (2012) Duloxetine versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews, 10, CD006533.
  2. Cipriani A, Purgato M, Furukawa TA, Trespidi C, Imperadore G, Signoretti A, Churchill R, Watanabe N & Barbui C (2012) Citalopram versus other anti-depressive agents for depression. Cochrane Database of Systematic Reviews, 7, CD006534.
  3. Furukawa TA, Horikoshi M, Kawakami N, Kadota M, Sasaki M, Sekiya Y, Hosogoshi H, Kashimura M, Asano K, Terashima H, Iwasa K, Nagasaku M, Grothaus LC & on behalf of the GENKI Project (2012) Telephone cognitive-behavioral therapy for subthreshold depression and presenteeism in workplace: a randomized controlled trial. PLoS ONE, 7, e35330.
  4. Johnston BC, Thorlund K, da Costa BR, Furukawa TA & Guyatt GH (2012) New methods can extend the use of minimal important difference units in meta-analyses of continuous outcome measures. Journal of Clinical Epidemiology, 65, 817-826.
  5. Kinoshita K, Kinoshita Y, Shimodera S, Nishida A, Inoue K, Watanabe N, Oshima N, Akechi T, Sasaki T, Inoue S, Furukawa TA & Okazaki Y (2012) Not only body weight perception but also body mass index is relevant to suicidal ideation and self-harming behavior in Japanese adolescents. Journal of Nervous and Mental Disease, 200, 305-309.
  6. Kinoshita Y, Kingdon D, Kinoshita K, Sarafudheen S, Umadi D, Dayson D, Hansen L, Rathod S, Ibbotson RB, Turkington D & Furukawa TA (2012) A semi-structured clinical interview for psychosis sub-groups (SCIPS): development and psychometric properties. Social Psychiatry and Psychiatric Epidemiology, 47, 563-580.
  7. Qin L, Shimodera S, Fujita H, Morokuma I, Nishida A, Kamimura N, Mizuno M, Furukawa TA & Inoue S (2012) Duration of untreated psychosis in a rural/suburban region of Japan. Early Intervention in Psychiatry, 6, 239-246.
  8. Shimodera S, Kato T, Sato H, Miki K, Shinagawa Y, Kondo M, Fujita H, Morokuma I, Ikeda Y, Akechi T, Watanabe N, Yamada M, Inagaki M, Yonemoto N, Furukawa TA & For the SUN(^_^)D Investigators (2012) The first 100 patients in the SUN(^_^)D trial (Strategic Use of New generation antidepressants for Depression): Examination of feasibility and adherence during the pilot phase. Trials, 13, 80.
  9. Shimodera S, Imai Y, Kamimura N, Morokuma I, Fujita H, Inoue S & Furukawa TA (2012) Mapping hypofrontality during letter fluency task in schizophrenia: a multi-channel near-infrared spectroscopy study. Schizophrenia Research, 136, 63-69.
  10. Shimodera S, Imai Y, Kamimura N, Morokuma I, Fujita H, Inoue S & Furukawa TA (2012) Near-infrared spectroscopy (NIRS) of bipolar disorder may be distinct from that of unipolar depression and of healthy controls. Asia-Pacific Psychiatry, 4, 258-265.
  11. Shimodera S, Furukawa TA, Mino Y, Shimazu K, Nishida A & Inoue S (2012) Cost-effectiveness of family psychoeducation to prevent relapse in major depression: Results from a randomized controlled trial. BMC Psychiatry, 12, 40.
  12. Shimodera S, Yonekura Y, Yamaguchi S, Kawamura A, Mizuno M, Inoue S, Furukawa TA & Mino Y (2012) Bipolar I disorder and expressed emotion of families: A cohort study in Japan. Open Journal of Psychiatry, 2, 258-261.
  13. Shimodera S, Kawamura A & Furukawa TA (2012) Physical pain associated with depression: results of a survey in Japanese patients and physicians. Comprehensive Psychiatry, 53, 843-849.
  14. Tsuchiya M, Kawakami N, Ono Y, Nakane Y, Nakamura Y, Fukao A, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Oorui M, Naganuma Y, Furukawa TA, Kobayashi M, Ahiko T, Takeshima T & Kikkawa T (2012) Impact of mental disorders on work performance in a community sample of workers in Japan: the World Mental Health Japan Survey 2002-2005. Psychiatry Research, 198, 140-145.
  15. Umeda M & Kawakami N (2012) Association of childhood family environments with the risk of social withdrawal ('hikikomori') in the community population in Japan. Psychiatry and Clinical Neurosciences, 66, 121-129.
  16. Watanabe N, Nishida A, Shimodera S, Inoue K, Oshima N, Sasaki T, Inoue S, Akechi T, Furukawa TA & Okazaki Y (2012) Deliberate self-harm in adolescents aged 12 to 18: A cross-sectional survey of 18104 students. Suicide and Life-Threatening Behavior, 42, 550-560.
  17. Watanabe N, Nishida A, Shimodera S, Inoue K, Oshima N, Sasaki T, Inoue S, Akechi T, Furukawa TA & Okazaki Y (2012) Help seeking behaviors among adolescents with self harm: Representative self-report survey of 18104 students. Neuropsychiatric Disease and Treatment, 8, 561-569.
  18. Yamada A, Kato M, Suzuki M, Watanabe N, Akechi T & Furukawa TA (2012) Quality of life of parents raising children with pervasive developmental disorders. BMC Psychiatry, 12, 119.
PAGE TOP

Major publications before 2011

  • Furukawa TA, Akechi T, Shimodera S, Yamada M, Miki K, Watanabe N, Inagaki M & Yonemoto N (2011) Strategic use of new generation antidepressants for depression: SUN(^_^)D study protocol. Trials, 12, 116.
  • Furukawa TA, Akechi T, Wagenpfeil S & Leucht S (2011) Relative indices of treatment effect may be constant across different definitions of response in schizophrenia trials. Schizophrenia Research, 126, 212-219.
  • Furukawa TA & Leucht S (2011) How to obtain NNT from Cohen's d: comparison of two methods. PLoS ONE, 6, e19070.
  • Shimazu K, Shimodera S, Mino Y, Nishida A, Kamimura N, Sawada K, Fujita H, Furukawa TA & Inoue S (2011) Family psychoeducation for major depression: randomised controlled trial. British Journal of Psychiatry, 198, 385-390.
  • Watanabe N, Furukawa TA, Shimodera S, Morokuma I, Katsuki F, Fujita H, Sasaki M, Kawamura C & Perlis ML (2011) Brief behavioral therapy for refractory insomnia in residual depression: an assessor-blind, randomized controlled trial. The Journal of Clinical Psychiatry, 72, 1651-1658.
  • Kessler RC, Green JG, Gruber MJ, Sampson NA, Bromet E, Cuitan M, Furukawa TA, Gureje O, Hinkov H, Hu CY, Lara C, Lee S, Mneimneh Z, Myer L, Oakley-Browne M, Posada-Villa J, Sagar R, Viana MC & Zaslavsky AM (2010) Screening for serious mental illness in the general population with the K6 screening scale: results from the WHO World Mental Health (WMH) survey initiative. International Journal of Methods in Psychiatric Research, 19 Suppl 1, 4-22.
  • Cipriani, A., Furukawa, T. A., Salanti, G., Geddes, J. R., Higgins, J. P., Churchill, R., Watanabe, N., Nakagawa, A., Omori, I. M., McGuire, H., Tansella, M. & Barbui, C. (2009) Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis. Lancet, 373, 746-758.
  • Furukawa, T. A., Chen, J., Watanabe, N., Nakano, Y., Ietsugu, T., Ogawa, S., Funayama, T. & Noda, Y. (2009) Videotaped experiments to drop safety behaviors and self-focused attention for patients with social anxiety disorder: Do they change subjective and objective evaluations of anxiety and performance? Journal of Behavior Therapy and Experimental Psychiatry, 40, 202-210.
  • Furukawa, T. A., Yoshimura, R., Harai, H., Imaizumi, T., Takeuchi, H., Kitamura, T. & Takahashi, K. (2009) How many well vs. unwell days can you expect over 10 years, once you become depressed? Acta Psychiatrica Scandinavica, 119, 290-297.
  • Furukawa TA, Katherine Shear M, Barlow DH, Gorman JM, Woods SW, Money R, Etschel E, Engel RR & Leucht S (2009) Evidence-based guidelines for interpretation of the Panic Disorder Severity Scale. Depression and Anxiety, 26, 922-929.
  • Barbui C, Furukawa TA & Cipriani A (2008) Effectiveness of paroxetine in the acute phase treatment of adults with major depression: a systematic re-examination of published and unpublished randomised data. Canadian Medical Association Journal, 178, 296-305.
  • Furukawa TA, Fujita A, Harai H, Yoshimura R, Kitamura T & Takahashi K (2008) Definitions of recovery and outcomes of major depression: results from a 10-year follow-up. Acta Psychiatrica Scandinavica, 117, 35-40.
  • Furukawa TA, Kawakami N, Saitoh M, Ono Y, Nakane Y, Nakamura Y, Tachimori H, Iwata N, Uda H, Nakane H, Watanabe M, Naganuma Y, Hata Y, Kobayashi M, Miyake Y, Takeshima T & Kikkawa T (2008) The performance of the Japanese version of the K6 and K10 in the World Mental Health Survey Japan. International Journal of Methods in Psychiatric Research, 17, 152-158.
  • Furukawa TA, Jaeschke R, Cook D & Guyatt G (2008) Measurement of patients' experience. In Users' Guides to the Medical Literature: A Manual for Evidence-Based Clinical Practice (2nd edn). (eds Guyatt G, Drummond R, Meade MO & Cook DJ), pp. 249-271. New York: The McGraw-Hill Companies, Inc.
  • Furukawa TA, Strauss S, Bucher HC & Guyatt G (2008) Diagnostic tests. In Users' Guides to the Medical Literature: A Manual for Evidence-Based Practice (2nd edn). (eds Guyatt G, Drummond R, Meade MO & Cook DJ), pp. 419-438. New York: The McGraw-Hill Companies, Inc.
  • Kinoshita Y, Chen J, Rapee RM, Bogels S, Schneier FR, Choy Y, Kwon JH, Liu X, Schramm E, Chavira DA, Nakano Y, Watanabe N, Ietzugu T, Ogawa S, Emmelkamp P, Zhang J, Kingdon D, Nagata T & Furukawa TA (2008) Cross-cultural study of conviction subtype Taijin Kyofu: proposal and reliability of Nagoya-Osaka diagnostic criteria for social anxiety disorder. Journal of Nervous and Mental Disease, 196, 307-313.
  • Furukawa TA, Watanabe N, Omori IM, Montori VM & Guyatt GH (2007) Association between unreported outcomes and effect size estimates in Cochrane meta-analyses. JAMA, 297, 468-470.
  • Furukawa TA, Akechi T, Azuma H, Okuyama T & Higuchi T (2007) Evidence-based guidelines for interpretation of the Hamilton Rating Scale for Depression. Journal of Clinical Psychopharmacology, 27, 531-534.
  • Furukawa TA, Cipriani A, Barbui C & Geddes JR (2007) Long-term treatment of depression with antidepressants: A systematic narrative review. Canadian Journal of Psychiatry. Revue Canadienne de Psychiatrie, 52, 545-552.
  • Tabuse H, Kalali A, Azuma H, Ozaki N, Iwata N, Naitoh H, Higuchi T, Kanba S, Shioe K, Akechi T & Furukawa TA (2007) The new GRID Hamilton Rating Scale for Depression demonstrates excellent inter-rater reliability for inexperienced and experienced raters before and after training. Psychiatry Research, 153, 61-67.
  • Watanabe N, Hunot V, Omori IM, Churchill R & Furukawa TA (2007) Psychotherapy for depression among children and adolescents: a systematic review. Acta Psychiatrica Scandinavica, 116, 84-95
  • Akechi T, Okuyama T, Sugawara Y, Shima Y, Furukawa TA & Uchitomi Y (2006) Screening for depression in terminally ill cancer patients in Japan. Journal of Pain and Symptom Management, 31, 5-12.
  • Cipriani A, Barbui C, Brambilla P, Furukawa T, Hotopf M & Geddes J (2006) Are all antidepressants really the same? The case of fluoxetine: a systematic review. Journal of Clinical Psychiatry, 67, 850-864.
  • Furukawa TA, Watanabe N & Churchill R (2006) Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review. British Journal of Psychiatry, 188, 305-312.
  • Furukawa TA, Barbui C, Cipriani A, Brambilla P & Watanabe N (2006) Imputing missing standard deviations in meta-analyses can provide accurate results. Journal of Clinical Epidemiology, 59, 7-10.
  • Furukawa TA & Guyatt GH (2006) Sources of bias in studies of diagnostic tests and the diagnostic process. Canadian Medical Association Journal, 174, 481-482.
  • Lee K, Noda Y, Nakano Y, Ogawa S, Kinoshita Y, Funayama T & Furukawa TA (2006) Interoceptive hypersensitivity and interoceptive exposure in patients with panic disorder: specificity and effectiveness. BMC Psychiatry, 6, 32.
  • Furukawa TA, Streiner DL, Azuma H, Higuchi T, Kamijima K, Kanba S, Ozaki N, Aoba A, Murasaki M & Miura S (2005) Cross-cultural equivalence in depression assessment: Japan-Europe-North American study. Acta Psychiatrica Scandinavica, 112, 279-285.
  • Furukawa TA, Cipriani A, Barbui C, Brambilla P & Watanabe N (2005) Imputing response rates from means and standard deviations in meta-analyses. International Clinical Psychopharmacology, 20, 49-52.
  • Hiroe T, Kojima M, Yamamoto I, Nojima S, Kinoshita Y, Hashimoto N, Watanabe N, Maeda T & Furukawa TA (2005) Gradations of clinical severity and sensitivity to change assessed with the Beck Depression Inventory-II in Japanese patients with depression. Psychiatry Research, 135, 229-235.
  • Kawakami N, Takeshima T, Ono Y, Uda H, Hata Y, Nakane Y, Nakane H, Iwata N, Furukawa TA & Kikkawa T (2005) Twelve-month prevalence, severity, and treatment of common mental disorders in communities in Japan: preliminary finding from the World Mental Health Japan Survey 2002-2003. Psychiatry and Clinical Neurosciences, 59, 441-452.
  • Sakurai A, Nagata T, Harai H, Yamada H, Mohri I, Nakano Y, Noda Y, Ogawa S, Lee K & Furukawa TA (2005) Is "relationship fear" unique to Japan? Symptom factors and patient clusters of social anxiety disorder among the Japanese clinical population. Journal of Affective Disorders, 87, 131-137.
  • Furukawa T (2004) Meta-analyses and megatrials: neither is the infallible, universal standard. Evidence-Based Mental Health, 7, 34-35.
  • Furukawa TA (2004) All clinical trials must be reported in detail and made publicly available. BMJ (Clinical Research Ed.), 329, 626.
  • Nakano Y, Oshima M, Sugiura-Ogasawara M, Aoki K, Kitamura T & Furukawa TA (2004) Psychosocial predictors of successful delivery after unexplained recurrent spontaneous abortions: a cohort study. Acta Psychiatrica Scandinavica, 109, 440-446.
  • Yamamoto I, Nakano Y, Watanabe N, Noda Y, Furukawa TA, Kanai T, Takashio O, Koda R, Otsubo T & Kamijima K (2004) Cross-cultural evaluation of the Panic Disorder Severity Scale in Japan. Depression and Anxiety, 20, 17-22.
  • Furukawa TA, Kessler RC, Slade T & Andrews G (2003) The performance of the K6 and K10 screening scales for psychological distress in the Australian National Survey of Mental Health and Well-Being. Psychological Medicine, 33, 357-362.
  • Geddes JR, Carney SM, Davies C, Furukawa TA, Kupfer DJ, Frank E & Goodwin GM (2003) Relapse prevention with antidepressant drug treatment in depressive disorders: a systematic review. Lancet, 361, 653-661.
  • Kanai T, Takeuchi H, Furukawa TA, Yoshimura R, Imaizumi T, Kitamura T & Takahashi K (2003) Time to recurrence after recovery from major depressive episodes and its predictors. Psychological Medicine, 33, 839-845.
  • Furukawa TA, Guyatt GH & Griffith LE (2002) Can we individualize the 'number needed to treat'? An empirical study of summary effect measures in meta-analyses. International Journal of Epidemiology, 31, 72-76.
  • Furukawa TA, McGuire H & Barbui C (2002) Meta-analysis of effects and side effects of low dosage tricyclic antidepressants in depression: systematic review. BMJ (Clinical Research Ed.), 325, 991-995.
  • Furukawa TA, Andrews G & Goldberg DP (2002) Stratum-specific likelihood ratios of the general health questionnaire in the community: help-seeking and physical co-morbidity affect the test characteristics. Psychological Medicine, 32, 743-748.
  • Kojima M, Furukawa TA, Takahashi H, Kawai M, Nagaya T & Tokudome S (2002) Cross-cultural validation of the Beck Depression Inventory-II in Japan. Psychiatry Research, 110, 291-299.
  • Sugiura-Ogasawara M, Furukawa TA, Nakano Y, Hori S, Aoki K & Kitamura T (2002) Depression as a potential causal factor in subsequent miscarriage in recurrent spontaneous aborters. Human Reproduction, 17, 2580-2584.
  • Furukawa TA, Goldberg DP, Rabe-Hesketh S & Ustun TB (2001) Stratum-specific likelihood ratios of two versions of the general health questionnaire. Psychological Medicine, 31, 519-529.
  • Furukawa TA, Streiner DL, Young LT & Kinoshita Y (2001) Antidepressants plus benzodiazepine for major depression. Cochrane Database of Systematic Reviews, Art. No.: CD001026. DOI: 001010.001002/14651858.CD14001026.
  • Furukawa TA, Kitamura T & Takahashi K (2000) Time to recovery of an inception cohort with hitherto untreated unipolar major depressive episodes. British Journal of Psychiatry, 177, 331-335.
  • Furukawa TA, Kitamura T & Takahashi K (2000) Treatment received by depressed patients in Japan and its determinants: naturalistic observation from a multi-center collaborative follow-up study. Journal of Affective Disorders, 60, 173-179.
  • Furukawa TA, Streiner DL & Hori S (2000) Discrepancies among megatrials. Journal of Clinical Epidemiology, 53, 1193-1199.
  • Furukawa TA (1999) From effect size into number needed to treat. Lancet, 353, 1680.
  • Furukawa T & Goldberg DP (1999) Cultural invariance of likelihood ratios for the General Health Questionnaire. Lancet, 353, 561-562.
  • Furukawa T, Nakanishi M & Hamanaka T (1997) Typus melancholicus is not the premorbid personality trait of unipolar (endogenous) depression. Psychiatry and Clinical Neurosciences, 51, 197-202.
  • Furukawa T & Shibayama T (1997) Intra-individual versus extra-individual components of social support. Psychological Medicine, 27, 1183-1191.
  • Furukawa T, Awaji R, Nakazato H & Sumita Y (1995) Predictive validity of subtypes of chronic affective disorders derived by cluster analysis. Acta Psychiatrica Scandinavica, 91, 379-385.
  • Furukawa T, Takahashi K, Kitamura T, Okawa M, Miyaoka H, Hirai T, Ueda H, Sakamoto K, Miki K & Fujita K (1995) The Comprehensive Assessment List for Affective Disorders (COALA): a polydiagnostic, comprehensive, and serial semistructured interview system for affective and related disorders. Acta Psychiatrica Scandinavica. Supplementum, 387, 1-36.
  • Furukawa T, Nakazato H & Sumita Y (1993) Characteristics of chronic outpatients with unipolar depression. Acta Psychiatrica Scandinavica, 88, 273-277.
  • Furukawa T & Sumita Y (1992) A cluster-analytically derived subtyping of chronic affective disorders. Acta Psychiatrica Scandinavica, 85, 177-182.
PAGE TOP